miR-139-5p inhibits aerobic glycolysis, cell proliferation, migration, and invasion in hepatocellular carcinoma via a reciprocal regulatory interaction with ETS1
Shengni Hua(Jinan University), Dehua Wu(Nanfang Hospital), Xuejing Zou(Nanfang Hospital), Ling Deng(Southern Medical University), Xie Weng(Southern Medical University), Li Liu(National Clinical Research Center for Digestive Diseases), Dongyan Zhang(Shandong University), Shuang Wang(Nanfang Hospital), Chengdong Liu(Jiangsu University), Xiaolong Qi(First Hospital of Lanzhou University), Chuanhui Cao(Ganzhou People's Hospital), Ling Lei(Nanfang Hospital)
Cited by 142
Related Papers
Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study)
|Hepatology International|2020|295
The Long Intergenic Noncoding RNA UFC1, a Target of MicroRNA 34a, Interacts With the mRNA Stabilizing Protein HuR to Increase Levels of β-Catenin in HCC Cells
|Gastroenterology|2014|231
ATR inhibitor AZD6738 enhances the antitumor activity of radiotherapy and immune checkpoint inhibitors by potentiating the tumor immune microenvironment in hepatocellular carcinoma
|Journal for ImmunoTherapy of Cancer|2020|225
Residual convolutional neural network for predicting response of transarterial chemoembolization in hepatocellular carcinoma from CT imaging
|European Radiology|2019|219
MicroRNA-647 Targets SRF-MYH9 Axis to Suppress Invasion and Metastasis of Gastric Cancer
|Theranostics|2017|114